Allergic Inflammation Caused by Dimerized Translationally Controlled Tumor Protein is Attenuated by Cardamonin

Overview of attention for article published in Frontiers in Pharmacology, October 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Therapeutic efficacy of JEW-M449, an anti-TCTP monoclonal antibody, administered via the nasal route in a BALB/c mouse model of ovalbumin-induced acute asthma

Article in Biomedicine & Pharmacotherapy (September 2024)

Mechanisms of exacerbation of Th2-mediated eosinophilic allergic asthma induced by plastic pollution derivatives (PPD): A molecular toxicological study involving lung cell ferroptosis and metabolomics

Article in The Science of The Total Environment (July 2024)

Targeting the translationally controlled tumor protein by a monoclonal antibody improves allergic airway inflammation in mice

Article in Biomedicine & Pharmacotherapy (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.